Cargando…
OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery in vitro, in situ, and in vivo
Targeted nanocarriers have shown great promise in drug delivery because of optimized drug behavior and improved therapeutic efficacy. How to improve the targeting efficiency of nanocarriers for the maximum possible drug delivery is a critical issue. Here we developed L-carnitine-conjugated nanoparti...
Autores principales: | Kou, Longfa, Sun, Rui, Xiao, Shuyi, Cui, Xiao, Sun, Jin, Ganapathy, Vadivel, Yao, Qing, Chen, Ruijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968687/ https://www.ncbi.nlm.nih.gov/pubmed/31913724 http://dx.doi.org/10.1080/10717544.2019.1710623 |
Ejemplares similares
-
Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery
por: Kou, Longfa, et al.
Publicado: (2020) -
Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB(0,+) to deliver chemotherapeutic agents for colon cancer therapy
por: Kou, Longfa, et al.
Publicado: (2017) -
Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy
por: Kou, Longfa, et al.
Publicado: (2019) -
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
por: Kou, Longfa, et al.
Publicado: (2018) -
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability
por: Wang, Gang, et al.
Publicado: (2020)